Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Behling

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Archiv Fur Geschwulstforschung|January 1, 1981
The behaviour of tumour cells of ovarian carcinomata under in vitro conditions and the coincidence with clinical controllability of tumoursW Krafft, D Brückmann, J Brückmann, et al.
Infection and Immunity|September 1, 1981
Humoral immunity and reduced periodontal bone loss in Eikenella corrodens-monoassociated ratsU H Behling, C Sallay, F Sanavi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1976
Synthetic glycolipid adjuvantsU H Behling, B Campbell, C M Chang, et al.
Zentralblatt Fur Gynakologie|January 1, 1985
[Prognostic significance of lymph node metastases in operable cervix cancer of categories T1 and T2]W Krafft, F Wagner, F Marzotko, et al.
Journal of Evolutionary Biology|July 13, 2022
Cross-kingdom transcriptomic trends in the evolution of hybrid gene expressionAnna H Behling, David J Winter, Austen R D Ganley, et al.
Zentralblatt Fur Gynakologie|January 1, 1979
[Effectiveness of supplemental bleomycin therapy in vulvar cancer]G Schmeisser, W Krafft, A Schirmer, et al.
Zentralblatt Fur Gynakologie|January 1, 1983
[Problems in the therapy of ovarian carcinoma with gestagen-acting hormones]W Krafft, R Steuckart, W Preibsch, et al.
Zentralblatt Fur Gynakologie|January 1, 1981
[Cytogenetic studies for detection of tumour strain lines of ovarian cancer cells (author's transl)]R Kademann, B Marx, W Krafft, et al.
Zentralblatt Fur Gynakologie|January 1, 1984
[Experiences with cisplatin (Platidiam) chemotherapy in secondary resistant ovarian carcinomas]W Krafft, Z Mechl, H Behling, et al.
Archiv Fur Geschwulstforschung|January 1, 1980
[The therapy of the early ovarian cancer (T1/T2 M0 N0) (author's transl)]W Krafft, G Morack, W Flach, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Archiv Fur Geschwulstforschung|January 1, 1981
The behaviour of tumour cells of ovarian carcinomata under in vitro conditions and the coincidence with clinical controllability of tumoursW Krafft, D Brückmann, J Brückmann, et al.
Infection and Immunity|September 1, 1981
Humoral immunity and reduced periodontal bone loss in Eikenella corrodens-monoassociated ratsU H Behling, C Sallay, F Sanavi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1976
Synthetic glycolipid adjuvantsU H Behling, B Campbell, C M Chang, et al.
Zentralblatt Fur Gynakologie|January 1, 1985
[Prognostic significance of lymph node metastases in operable cervix cancer of categories T1 and T2]W Krafft, F Wagner, F Marzotko, et al.
Journal of Evolutionary Biology|July 13, 2022
Cross-kingdom transcriptomic trends in the evolution of hybrid gene expressionAnna H Behling, David J Winter, Austen R D Ganley, et al.
Zentralblatt Fur Gynakologie|January 1, 1979
[Effectiveness of supplemental bleomycin therapy in vulvar cancer]G Schmeisser, W Krafft, A Schirmer, et al.
Zentralblatt Fur Gynakologie|January 1, 1983
[Problems in the therapy of ovarian carcinoma with gestagen-acting hormones]W Krafft, R Steuckart, W Preibsch, et al.
Zentralblatt Fur Gynakologie|January 1, 1981
[Cytogenetic studies for detection of tumour strain lines of ovarian cancer cells (author's transl)]R Kademann, B Marx, W Krafft, et al.
Zentralblatt Fur Gynakologie|January 1, 1984
[Experiences with cisplatin (Platidiam) chemotherapy in secondary resistant ovarian carcinomas]W Krafft, Z Mechl, H Behling, et al.
Archiv Fur Geschwulstforschung|January 1, 1980
[The therapy of the early ovarian cancer (T1/T2 M0 N0) (author's transl)]W Krafft, G Morack, W Flach, et al.
Pageof 5